Abstract
Aims Acute bouts of ultra-endurance exercise may cause an acute reduction in cardiac function, causing a physiological cascade which releases cardiac biomarkers. This study set out to determine the cardiac stress and recovery of participation in a three-day ultra-endurance mountain biking event of athletes using heart rate variability (HRV) as an outcome measure.
Methods Sixteen healthy participants (male and female) participating in a three-day ultra-endurance mountain biking event underwent a five-minute resting ECG recording in a supine position. Heart rate variability measurements were recorded two days before the race (baseline testing), after each race day, and at 24-hour post-event (recovery).
Results Time-domain and frequency domain measures showed significant (p≤0.05) changes from baseline in HRV parameters after each race day. The significant changes in HRV parameters reflected an increase in sympathetic activity after each day of the event. Our data revealed that the mean HR and RR variability variables did not return to baseline value after 24-hours of recovery, reflecting autonomic nervous system dysfunction, and that changes persisted for at least 24-hours post-event.
Conclusion Our study shows that competing in an ultra-endurance mountain bike event led to diminished vagal activity and a decrease in HRV throughout the event and persisted for at least 24-hours post-event. The body was under continuous sympathetic dominance during rest as well as during each day of racing, implying each race day can be considered a physiological stress. This may, in turn, cause a disturbance in homeostasis and an increase in autonomic nervous system dysfunction. This has implications for further research, including dysrhythmia risk, and monitoring of athletes in advising a return to strenuous activity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None sources of funds were received by a second party.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical considerations were observed and ethics approval was granted by the Biomedical Research Ethics Committee (BREC) and Research Management Committee (RMC), Ministry of Health and Social Services in Namibia and the Humans Research Ethics Committee (Medical) of the University of the Witwatersrand, South Africa (clearance certificate M171037).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data underlying this article will be shared on reasonable request to the corresponding author. For the duration of retention of records, each participants health records and measurements are held by following the guidelines of the Health Professional Council of South Africa (HPCSA) and Health Professional Council of Namibia (HPCNA). All hard copy records are stored in a safe place with electronic copies uploaded to online cloud storage, safeguarded by a password. All records and measurements are stored for a period of not less than six years and only the principle researcher has access to these records. Indirect identifiers (numbers) replaced all obvious identifiers (example name and surname) of participants in the main data set to retain confidentiality. A separate data set known as the Key holds the indirect identifiers with the obvious identifiers.
